Randomized controlled trial of sulforaphane and metabolite discovery in children with Autism Spectrum Disorder

Abstract Background Sulforaphane (SF), an isothiocyanate in broccoli, has potential benefits relevant to autism spectrum disorder (ASD) through its effects on several metabolic and immunologic pathways. Previous clinical trials of oral SF demonstrated positive clinical effects on behavior in young m...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Andrew W. Zimmerman, Kanwaljit Singh, Susan L. Connors, Hua Liu, Anita A. Panjwani, Li-Ching Lee, Eileen Diggins, Ann Foley, Stepan Melnyk, Indrapal N. Singh, S. Jill James, Richard E. Frye, Jed W. Fahey
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	BMC 2021-05-01
Serie:	Molecular Autism
Soggetti:	Sulforaphane Clinical trial Autism spectrum disorder (ASD) Biomarkers Placebo effects
Accesso online:	https://doi.org/10.1186/s13229-021-00447-5
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!